News & Articles

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Promega automated sample preparation solution added to CDC COVID-19 test protocol

Interim data shows strong antibody and T-cell responses in all evaluated participants

Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms

xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool

The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs

The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline

Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases

The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand

Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research

Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management

The platform aims to deliver rapid and automated processing of human blood and blood products to obtain purified populations of immune cells

binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings

Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein

Providing researchers with expanded capabilities in interrogating the tissue microenvironment

The partnership aims to provide accessible solutions for labs involved in COVID-19 testing

Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019

Our new expert webinar series aims to help you get the most from your microbiology research